Skip to main content
. Author manuscript; available in PMC: 2013 Aug 28.
Published in final edited form as: J Am Coll Surg. 2012 Mar 6;214(4):409–426. doi: 10.1016/j.jamcollsurg.2011.12.040

Table 3.

Islet Function Status According to Number of IE/Kg Transplanted

6 Month Follow-up 12 Month Follow-up 24 Month Follow-up 36 Month Follow-up C-Peptide Positive* (> 0.6 ng/ml) % w/mean HbA1c < 7.0%**

% (N)
< 2500 IE/Kg (75) (75) (54) (33) 79% 71%
 Insulin Independent 13% (10) 13% (8) 15% (8) 12% (4)
 Partial Function 56% (42) 53% (40) 48% (26) 33% (11)
 Insulin Dependent 31% (23) 36% (27) 37% (20) 55% (18)

2500–5000 IE/Kg (82) (83) (62) (37) 97% 86%
 Insulin Independent 20% (16) 23% (19) 31% (19) 22% (8)
 Partial Function 78% (64) 72% (60) 60% (37) 62% (23)
 Insulin Dependent 2% (2) 5% (4) 10% (6) 16% (6)

>5000 IE/Kg (49) (49) (31) (25) 100% 94%
 Insulin Independent 31% (15) 55% (27) 65% (20) 72% (18)
 Partial Function 67% (33) 43% (21) 32% (10) 24% (6)
 Insulin Dependent 2% (1) 2% (1) 3% (1) 4% (1)
*

Percent of patients in each islet yield category with C-Peptide Positive values greater than 0.6 ng/ml

**

Percent of patients in each islet yield category with mean Hb/A1c levels over time at less than 7.0%